Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES
GLOBETECH PUBLISHING

Urine Culture Updates Approach to Diagnosing Infection

By Labmedica International staff writers
Posted on 05 Dec 2013
Image: Flash and Grow Automatic Colony Counter (Photo courtesy of Rapidmicrobiology).
Image: Flash and Grow Automatic Colony Counter (Photo courtesy of Rapidmicrobiology).
The cause of acute uncomplicated cystitis is determined based on cultures of voided midstream urine, but few data guide the interpretation of such results, especially when gram-positive bacteria grow.

Interpreting a midstream urine culture is complicated by the potential for the specimen to become contaminated by microorganisms in the periurethra, making it difficult to distinguish whether the bacteria originated in the bladder or the periurethra.

Scientists at the Miller School of Medicine (University of Miami; FL, USA) collected midstream urine samples and catheter-derived urine from 202 women who presented with urinary tract infections (UTI) symptoms. The goal was to compare microbial species and colony counts from both samples, with the catheter urine used as the reference. Women were eligible if they were between the ages of 18 and 49 years, were in good general health, and had had typical symptoms of cystitis, dysuria and urinary frequency or urgency for seven days or less.

In catheter urine cultures, all microorganisms were fully identified and quantified to 10 colony forming units (CFU)/mL. In midstream urine cultures, all uropathogens, gram-negative rods, enterococci, group B streptococci, and Staphylococcus saprophyticus, were identified and quantified to 10 CFU/mL. Pyuria was defined as eight or more leukocytes/cu mm. The scientists found that found that even at very low counts of 102 CFU/mL, the presence of Escherichia coli in midstream urine had a high rate of predicting the presence of bacteriuria in the bladder. In contrast, the presence of enterococci and group B streptococci in midstream urine was not predictive of bladder bacteriuria in any amount.

Many commercial laboratories routinely report growth only for counts of 104 CFU/mL, cultures with lower E. coli counts may be falsely reported as negative. Conversely, midstream urine cultures often reveal enterococci and group B streptococci in amounts of 104 CFU/mL or higher, but these organisms appear to rarely cause cystitis in young women.

Thomas M. Hooton, MD, the lead author and a professor of medicine, said, “The study results reinforce the opinion of many that the voided urine culture for diagnosis of cystitis has limited value. If, however, clinicians use a voided urine culture in evaluating a symptomatic patient, the laboratory should be asked to quantify gram-negative bacteria, especially E. coli, down to 102 CFU/mL, and that low counts, even when in mixed growth with other organisms, should not be ignored. The study was published on November 14, 2013, in the New England Journal of Medicine.

Related Links:

Miller School of Medicine




EUROIMMUN AG
Sekisui Diagnostics
PURITAN MEDICAL
comments powered by Disqus
Life Technologies

Channels

Clinical Chemistry

view channel
Image: Enzyme-linked immunosorbent kit (ELISA) specific for human copeptin (Photo courtesy of USCN Life Science).

Preeclampsia Biomarker Detected Very Early In Pregnancy

A biomarker has been discovered that could give expecting mothers and their doctors the first simple blood test to reliably predict that a pregnant woman may develop preeclampsia, at least as early as... Read more

Pathology

view channel
Image: Glioblastoma multiforme (GBM) (Photo courtesy of the University of California, San Diego School of Medicine).

Brain Tumor Chemotherapy Biomarkers Identified

Cancer researchers have identified a new biomarker that they believe can predict whether glioblastoma multiformes (GBMs), the most common and aggressive type of malignant brain tumor, will be susceptible... Read more

Lab Tech.

view channel
Image: The ADVIA Centaur XPT Immunoassay System delivers the results that clinicians depend upon for accurate diagnoses and better patient care (Photo courtesy of Siemens Healthcare).

Introduction of New Central Laboratory Clinical Analyzers Highlights Recent Lab Equipment Exposition

An impressive array of new automated analyzers for central diagnostic laboratories was unveiled at a recent lab equipment trade fair. The IFCC WorldLab exposition held June 22-26, 2014, in Istanbul... Read more

Industry News

view channel

EKF Wins Distribution Contract and Regulatory Approval for Target Regions

EKF Diagnostics Holdings (Cardiff, Wales, UK), an AIM-listed point-of-care, central laboratory and molecular diagnostics business, announced that it has signed a new distribution contract in China and that one of its OEM (original equipment manufacturer) partners has received further regulatory approval across several target... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.